What will the war in the Middle East mean for Irish consumers? From heating bills to mortgages

Heating oil has shot up in price, petrol and diesel may continue to climb, but it may take longer to see the effect on ...

AI use in diagnostic care, rural care access, and surge in preventable diseases top annual report of patient safety concerns

WILLOW GROVE, Pa., March 9, 2026 /PRNewswire/ -- Balancing the potential benefits and risks of artificial intelligence (AI) in clinical diagnosis is the #1 patient safety concern for 2026 according to ...
National Hockey League

Schenn, Pearson bring wealth of experience to Buffalo

The right-shot Schenn is now one of eight healthy defensemen on Buffalo’s roster, and he should see third-pair opportunities ...
The Manila Times

Novartis Cosentyx® receives FDA approval for pediatric patients aged 12+ with moderate to severe hidradenitis suppurativa

Cosentyx is the only IL-17A inhibitor approved for this population, and the first differentiated mechanism in nearly a ...
Le Lézard

BIMZELX®?(bimekizumab) superior to SKYRIZI® (risankizumab) in BE BOLD: first head-to-head study in active psoriatic arthritis (PsA) to demonstrate superiority in ACR50

UCB, a global biopharmaceutical company, today announced positive topline data from the BE BOLD trial assessing BIMZELX® (bimekizumab) versus SKYRIZI® (risankizumab) in adults with active psoriatic ...